Philip R. Hagerman, Chairman and CEO, 10% Owner at Diplomat Pharmacy, Inc. (DPLO), sold 1,137,000 shares at $33.60 ($38.2M) on 2015-12-07, disclosed to the SEC on 2015-12-08.
Open-market sale of $38.2M DPLO by Chairman and CEO, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.60 | 220,000 | $7.4M | 19.3% |
| 2 | $33.60 | 230,000 | $7.7M | 20.2% |
| 3 | $33.60 | 311,000 | $10.4M | 27.4% |
| 4 | $33.60 | 376,000 | $12.6M | 33.1% |
| Total | $33.60 avg | 1,137,000 | $38.2M | 100% |
| Filing → |
| DPLO | SELL | 2018-09-13 | $6.9M | — | Filing → |
| DPLO | SELL | 2018-03-12 | $58.3M | — | Filing → |
| DPLO | SELL | 2015-03-27 | $38.5M | — | Filing → |